Billy Smith, MD
Physical Medicine & Rehabilitation · Greenville, NCNPI 1346275260
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 645 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,020 and has fallen 82.0% since, to $364 in 2025. Among physical medicine & rehabilitation clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 645 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$2K
- Forte Bio-pharma LLC$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$888
- Scilex Pharmaceuticals Inc.$742
- AbbVie$645
- Redhill Biopharma Inc.$388
- plus $4K from 33 others
What the payments were for
- Food & beverage$9,52999%
- Education$911%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,621 in reported general payments places this provider in the 95th percentile of 269 physical medicine & rehabilitation providers in North Carolina.
See all physical medicine & rehabilitation providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 174 | $155,000 |
| OxycontinOxycodone Hcl | 105 | $97,089 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 373 | $38,809 |
| Oxymorphone Hcl ErOxymorphone Hcl | 43 | $30,666 |
| OzempicSemaglutide | 19 | $18,882 |
| Oxycodone Hcl | 703 | $14,435 |
| MovantikNaloxegol Oxalate | 24 | $9,786 |
| Fentanyl | 91 | $9,443 |
| ZtlidoLidocaine | 18 | $8,570 |
| LinzessLinaclotide | 14 | $8,563 |
| Morphine Sulfate ErMorphine Sulfate | 251 | $8,479 |
| Naloxone Hcl | 81 | $5,318 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 187 | $5,241 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 20 | $3,935 |
| Gabapentin | 126 | $1,587 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $1,939 | $155,000174 claims |
| Novo NordiskOzempic | $37 | $18,88219 claims |
| Redhill Biopharma Inc.Movantik | $388 | $9,78624 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $742 | $8,57018 claims |
| AbbVieLinzess | $645 | $8,56314 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate, Buprenorphine Hcl | $136 | $4,71850 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 269 physical medicine & rehabilitation providers in North Carolina.
Other physical medicine & rehabilitation in Greenville
- Elizabeth BagsbyGreenville$33K
- Ratnakar VeeramachaneniGreenville$8K
- Jason GuoGreenville$3K
- William RieckGreenville$3K
- Patrick CleggGreenville$2K
- Andrew SumichCharlotte$181K
- Patrick O BrienRaleigh$86K
- Krishna BhatSanford$30K
- Jasbir DhaliwalSanford$23K
- Jimmy MaliDurham$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.